US › Healthcare

Electrocore LLC (ECOR)

US · Healthcare · Medical Devices

$7.85-5.99%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$9.4M

Revenue YoY

+28.0%

Net profit

$-3.1M

EPS

$-0.33

EPS estimate

$-0.41

Net margin

-32.4%

EPS came in at -0.33 against a street estimate of -0.41 — a beat of 19.5%.

Key statistics

Market cap

$87.1M

Forward P/E

384.6

P/B

34.89

Book value

$-0.31

EPS (TTM)

$-1.65

52-week high

$12.70

52-week low

$4.41

50-day MA

$9.70

200-day MA

$7.53

Beta

1.05

Analyst view

Analysts rate Electrocore LLC a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $19.17.

Shareholding

Insiders

34.19%

Institutions

11.64%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	2.35%
FourWorld Capital Management LLC	1.04%
Wexford Capital LP	1.02%
Geode Capital Management, LLC	0.81%
Northern Trust Corp	0.74%
Jane Street Group LLC	0.70%
JAFFETILCHIN INVESTMENT PARTNERS, LLC	0.65%
Sontag Advisory LLC	0.53%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Electrocore LLC — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.